The BIO-TIC market roadmap aims at providing a comprehensive overview of the market potential for industrial biotechnology and of the value chain composition and stakeholders in various product segments. The market roadmap also contributes to the technological and non-technological roadmaps by identifying R&D needs and policy or regulatory hurdles that need to be overcome in order to realise the market opportunities.


Based on a market analysis, the current (2013) EU market for the IB sector as a whole can be estimated at 28 billion EUR. By far the largest product segment is antibiotics, followed by biogas and bioethanol. In the future, the IB market is estimated to reach 41 billion EUR in 2020, and 52 billion EUR in 2030.

Estimated IB market demand in the EU up to 2030


Hurdles and proposed solutions

The market-related hurdles of IB are related to cost competitiveness, image and functionality. The cost competitiveness of IB compared to current products/techniques is a market challenge, calling, amongst others, for:

  • the creation of fair competition for biomass with other sectors that currently benefit from subsidising schemes,
  • measures to bring down biomass transport costs,
  • efficient recycling systems enabling new types of feedstock,
  • improved process efficiency,
  • technologies for economically feasible small volume production,
  • development of new and added value products to global markets, and
  • support for commercialisation and investments and for the creation of early-stage demand.

In terms of image, the IB sector calls for an improved public perception, thus reducing the brand risk of IB. This would require new solutions to demonstrate the environmental benefits, to communicate with consumers (GMO and food/fuel debates), and ultimately, to enable a bio-premium.

In the area of functionality, some areas are still dictated by need for “drop-in” products. This hinders opportunities for new products which may be more economically viable to produce.

Product segment specific information on market projections, value chains and perceived barriers to market entry can be found in the market roadmap document.


Download the complete version of the roadmap here.
Your input is important to us. Send your comments to the co-ordinator of the BIO-TIC project, Claire Gray, at

diazepam online no prescription diazepam online without prescription order diazepam online buy ultram without prescriptions ultram online no prescription buy ultram online no prescription overnight provigil overnight shipping buy provigil online cheap provigil no prescription buy soma for dogs buy soma without prescription cheap soma buy phentermine with mastercard buy phentermine online no prescription phentermine online tramadol generic buy tramadol no prescription buy tramadol no prescription overnight adipex generic buy adipex online no prescription adipex online buy valium free shipping buy valium online no prescription buy cheap valium buy xanax tablet xanax online no prescription buy xanax cheap no prescription buy klonopin no prescription buy klonopin online without prescription klonopin no rx